Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junbo Ge

Showing results (1141-1150 of 1,174) with videos related to

Pageof 118
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 23, 2024
Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerative mitral regurgitation: one-year results of the DRAGONFLY-DMR trialJian'an Wang, Xianbao Liu, Zhaoxia Pu, et al.
Circulation|November 19, 2019
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HFJohn J V McMurray, Alice M Jackson, Carolyn S P Lam, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 14, 2025
SIRT6 Lysine-Demyristoylates ATF2 to Ameliorate Vascular Injury via PRKCD/VE-Cadherin Pathway Regulating Vascular Endothelial BarrierRunyang Feng, Zheyan Fang, Shuang Zhao, et al.
Global Heart|November 16, 2022
Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 StudyDorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Global Heart|July 15, 2022
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 StudyDorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 5, 2023
Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world studyZhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, et al.
Circulation. Heart Failure|April 19, 2021
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialJasper Tromp, Brian L Claggett, Jiankang Liu, et al.
Experimental and Therapeutic Medicine|January 18, 2024
Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar<sup>®</sup>) in older patients with essential hypertension: Subgroup analysis from the Sevikar studyZhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, et al.
European Journal of Preventive Cardiology|August 29, 2025
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIREJaimini Cegla, Catriona Jennings, Eanna Kenny, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 8, 2020
[Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19 (first edition)]Jun Bu, Mao Chen, Xiaoshu Cheng, et al.
Pageof 118

Showing results (1141-1150 of 1,174) with videos related to

Sort By:
Pageof 118
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 23, 2024
Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerative mitral regurgitation: one-year results of the DRAGONFLY-DMR trialJian'an Wang, Xianbao Liu, Zhaoxia Pu, et al.
Circulation|November 19, 2019
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HFJohn J V McMurray, Alice M Jackson, Carolyn S P Lam, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 14, 2025
SIRT6 Lysine-Demyristoylates ATF2 to Ameliorate Vascular Injury via PRKCD/VE-Cadherin Pathway Regulating Vascular Endothelial BarrierRunyang Feng, Zheyan Fang, Shuang Zhao, et al.
Global Heart|November 16, 2022
Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 StudyDorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Global Heart|July 15, 2022
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 StudyDorairaj Prabhakaran, Kavita Singh, Dimple Kondal, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 5, 2023
Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world studyZhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, et al.
Circulation. Heart Failure|April 19, 2021
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialJasper Tromp, Brian L Claggett, Jiankang Liu, et al.
Experimental and Therapeutic Medicine|January 18, 2024
Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar<sup>®</sup>) in older patients with essential hypertension: Subgroup analysis from the Sevikar studyZhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, et al.
European Journal of Preventive Cardiology|August 29, 2025
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIREJaimini Cegla, Catriona Jennings, Eanna Kenny, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 8, 2020
[Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19 (first edition)]Jun Bu, Mao Chen, Xiaoshu Cheng, et al.
Pageof 118